NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
25/09/2023
Voltar para busca
Dado oficial do USPTO
CYTORI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
25/09/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10
Data de depósito
14/09/2016
Data de registro
09/01/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/09/2023
Última transação
25/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Principal Register
Primeiro uso
2008-06-00
Primeiro uso no comércio
2008-06-00
Código do desenho
3
Tipo de titular
24
Localização do titular
SAN DIEGO, CA
Examinador
NEVILLE, BRIAN
Unidade examinadora
M50
Descrição da marca
The mark consists of the word "cytori" to the right of two connected infinity designs at an angle and extending above the "c".
Titulares e representantes
Titulares
LOREM VASCULAR PTE. LTD.
Cytori Therapeutics, Inc.
Representantes
Jonathan Soneff Law Offices of Jonathan Soneff
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
CHEMICAL PREPARATIONSBIOLOGICALLY COMPATIBLE CHEMICAL SUBSTANCES FOR SCIENTIFICLABORATORYCLINICAL AND MEDICAL RESEARCH; BIOLOGICAL TISSUE FOR USE IN SCIENTIFICLABORATORYCLINICAL AND MEDICAL RESEARCH; THERAPEUTIC TISSUETHERAPEUTIC TISSUE COMPRISING OR DERIVED FROM STEM CELLS OR PROGENITOR CELLSCOMPOSITIONS COMPRISING OR DERIVED FROM THE THERAPEUTIC TISSUES FOR SCIENTIFICLABORATORYCLINICAL AND MEDICAL RESEARCH
Classe 5
PREPARATIONS COMPRISING LIVING CELLS AND NON-SYNTHETIC CELLULAR SOLIDS AND FLUIDS FOR PLACEMENT ON OR INTO THE MAMMALIAN BODYFOR THE TREATMENT OF DISORDERSDISEASES AND INJURIES AND FOR COSMETIC DEFECTS; BIOLOGICAL IMPLANTSBIOLOGICAL IMPLANTS COMPRISING OR DERIVED FROM STEM CELLS OR PROGENTIOR CELLS; SURGICAL IMPLANTSSURGICAL IMPLANTS COMPRISING LIVING TISSUE; IMPLANTABLEINJECTIBLE PREPARATIONS COMPRISING OR DERIVED FROM STEM CELLS OR PROGENITOR CELLS FOR MEDICAL PURPOSESFOR THE TREATMENT OF VASCULARFIBROTICINFLAMMATORY CONDITIONS AND DISEAES AND COSMETIC DEFECTS; CHEMICALS AND CHEMCIAL PREPARATIONS AND REAGENTS COMPRISING NON-SYNTHETIC CELLULAR COMPOSITIONS FOR MEDICAL PURPOSESFOR THE TREATMENT OF VASCULARFIBROTICINFLAMMATORY CONDITIONS AND DISEAES AND COSMETIC DEFECTS; THERAPEUTIC TISSUECELLULAR AND STEM CELL COMPOSITIONS FOR PLACEMENT ON OR INTO THE MAMMALIAN BODY FOR MEDICAL USEFOR THE TREATMENT OF VASCULARFIBROTICINFLAMMATORY CONDITIONS AND DISEAES AND COSMETIC DEFECTS; TISSUECELL AND STEM CELL COMPOSITIONS FOR PLACEMENT ON OR INTO THE MAMMALIAN BODY FOR THE TREATMENT OF COSMETIC DEFECTS AND FOR THE TREATMENT OF VASCULARFIBROTICINFLAMMAOTRY CONDITIONS; BIOLOGICAL PREPARATIONS AND REAGENTS FOR PLACEMENT INTO CONTACT WITH THE MAMMALIAN BODY FOR THE TREATMENT OF COSMETIC DEFECTS AND VASCULARFIBROTIC AND INFLAMMATORY DISORDERSDISEASES AND INJURIES
Classe 10
MEDICAL APPARATUSESINSTRUMENTS AND ARTICLESMEDICAL INSTRUMENTS FOR PROCESSINGCONCENTRATING AND IMPLANTING CELLS AND CELLULAR COMPOSITIONS; MEDICAL INSTRUMENTS FOR TISSUECELLCELLULAR COMPONENT AND STEM CELL EXTRACTIONPROCESSING AND APPLICATION; TISSUE AND CELL SEPARATION AND PURIFICATION DEVICESMEDICAL DEVICES USED FOR THE ISOLATION OF CELLS AND CELLULAR COMPONENTS WITHIN ADIPOSE TISSUE; TISSUE AND CELL PROCESSING DEVICESMEDICAL DEVICES USED FOR THE COLLECTION AND STORAGE OF ADIPOSE TISSUE AND ADIPOSE TISSUE DERIVED CELLS
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
25/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/09/2023
ES8R
TEAS SECTION 8 RECEIVED
10/05/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/06/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/05/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
31/07/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22/05/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2017
PUBO
PUBLISHED FOR OPPOSITION
24/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/08/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/08/2017
GNRT
NON-FINAL ACTION E-MAILED
22/08/2017
CNRT
NON-FINAL ACTION WRITTEN
22/08/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/08/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
18/07/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
30/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/06/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
27/06/2017
ALIE
ASSIGNED TO LIE
27/06/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/06/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
27/06/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2017
DOCK
ASSIGNED TO EXAMINER
24/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/12/2016
GNRT
NON-FINAL ACTION E-MAILED
19/12/2016
CNRT
NON-FINAL ACTION WRITTEN
19/12/2016
DOCK
ASSIGNED TO EXAMINER
14/12/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
20/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/09/2016
NWAP
NEW APPLICATION ENTERED
17/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CYTORI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.